WOCKPHARMA2022-10-012022-12-31 WOCKPHARMA2022-10-012022-12-31 WOCKPHARMA2022-10-012022-12-31in-bse-fin:OneOperatingExpenses01Member WOCKPHARMA2022-10-012022-12-31in-bse-fin:FourOperatingExpenses01Member WOCKPHARMA2022-12-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 532300 WOCKPHARMA NA Wockhardt Limited Equity 2022-04-01 2023-03-31 2023-02-13 2023-02-03 INR Crores Third quarter 11:45:00 14:50:00 2023-02-13 2023-02-13 Not applicable Single segment Pharmaceuticals 2022-10-01 2022-12-31 Unaudited Standalone 2820000000.00 180000000.00 3000000000.00 500000000.00 580000000.00 -20000000.00 630000000.00 520000000.00 470000000.00 870000000.00 3550000000.00 -550000000.00 0.00 -550000000.00 0.00 0.00 0.00 0.00 -550000000.00 0.00 0.00 0.00 0.00 -550000000.00 0.00 -550000000.00 0.00 0.00 720000000.00 5 -3.81 -3.81 0.00 0.00 -3.81 -3.81 0.00 0.00 0.00 1. For Notes to Standalone Results, please refer the Notes from the Statement of Standalone Unaudited Results for the quarter and nine months ended Decemberr 31, 2022 as attached which is submitted under Outcome of Board Meeting uploaded today on Stock Exchange. 2. EPS for the quarter and nine months ended December 31, 2022 is not annualised Single segment 2022-04-01 2022-12-31 Unaudited Standalone 7810000000.00 960000000.00 8770000000.00 1400000000.00 1400000000.00 70000000.00 1880000000.00 1710000000.00 1410000000.00 2640000000.00 10510000000.00 -1740000000.00 -500000000.00 -2240000000.00 0.00 -570000000.00 -570000000.00 0.00 -1670000000.00 0.00 0.00 0.00 0.00 -1670000000.00 -10000000.00 -1680000000.00 0.00 0.00 720000000.00 5 -11.60 -11.60 0.00 0.00 -11.60 -11.60 0.00 0.00 0.00 Other expenses 870000000.00 Other expenses 2640000000.00 0.00 -10000000.00 0.00 0.00 0.00 0.00